Mobile Gamma Cameras Manufacturing Market Size, CAGR, Trends and Growth Report Forecast 2025–2033
- Rahul Pal
- Nov 28, 2025
- 4 min read
The global Mobile Gamma Cameras market was valued at USD 57.8 Million in 2024 and is projected to reach USD 79.2 Million by 2033, growing at a CAGR of 3.39% during the forecast period 2025-2033. This growth is driven by advancements in medical imaging, rising chronic disease prevalence, and demand for portable diagnostic devices, especially in oncology and cardiology. North America leads with over 35% market share due to advanced healthcare infrastructure and government initiatives. For detailed insights
Study Assumption Years
Base Year: 2024
Historical Years: 2019-2024
Forecast Period: 2025-2033
Mobile Gamma Cameras Market Key Takeaways
The global mobile gamma cameras market size was valued at USD 57.8 Million in 2024.
The market is forecast to grow at a CAGR of 3.39% from 2025 to 2033.
North America dominates with over 35% market share in 2024.
Single-head mobile gamma cameras hold the largest product segment share at 62.9% in 2024 due to cost-effectiveness and versatility.
Thyroid scanning is the leading application segment owing to its critical role in diagnosing thyroid disorders.
Hospitals constitute the largest end-user segment with 41.3% share in 2024, supported by extensive infrastructure and patient volume.
Sample Request Link:
Market Growth Factors
The mobile gamma cameras market is bolstered by the increasing prevalence of chronic diseases globally. According to the WHO, noncommunicable diseases (NCDs) cause 41 million deaths annually, representing 74% of global fatalities. Cancer alone claimed approximately 10 million lives in 2020. This rising disease burden drives demand for gamma cameras used especially during radio-guided surgery. Additionally, growing healthcare expenditures worldwide and rising disposable incomes are key drivers incentivizing market expansion.
Technological advancements play a pivotal role in market growth. Improved imaging modalities such as solid-state detectors, high-energy collimators, and software integration have enhanced resolution and data processing capabilities of mobile gamma cameras. Integration of artificial intelligence and machine learning improves diagnostic accuracy, fostering greater adoption in oncology and cardiology. These innovations enable minimally invasive diagnostics and workflow efficiencies in healthcare.
The shift toward portable and point-of-care diagnostic solutions further fuels the market. Unlike traditional stationary gamma cameras requiring dedicated suites, mobile units provide flexibility for bedside imaging in outpatient and emergency settings. This mobility is critical for patients with limited mobility and supports decentralized healthcare access in rural or resource-constrained settings. Cost effectiveness, improved operational efficiency, and healthcare model decentralization accelerate the adoption of mobile gamma cameras globally.
Market Segmentation
By Product:
Single-head Mobile Gamma Cameras: Largest segment with 62.9% share in 2024; notable for cost-effectiveness, versatility, and suitability for point-of-care, outpatient, and rural healthcare applications.
Dual-head Mobile Gamma Cameras
Triple-head Mobile Gamma Cameras
Handheld Mobile Gamma Camera
By Application:
Thyroid Scanning: Dominates market due to critical diagnostic role for thyroid disorders. Mobile gamma cameras enhance accessibility in outpatient and rural areas by detecting radioactive isotope uptake. Portable and non-invasive nature supports affordable diagnostics.
Cardiac Imaging
Breast Imaging
Kidney Scanning
Intraoperative Imaging
Brain Imaging
Others
By End User:
Hospitals: Largest segment with 41.3% market share in 2024; extensive infrastructure, high patient volumes, and skilled professionals support wide use.
Ambulatory Surgical Centers
Research Centers
Imaging Centers and Clinics
Regional Insights
North America dominates the global mobile gamma cameras market with a 35.0% share in 2024. This leadership is attributed to advanced healthcare infrastructure, high healthcare expenditures, and swift adoption of cutting-edge medical technologies. The region's high prevalence of chronic diseases like cancer and cardiovascular disorders necessitates advanced diagnostics. An aging population further escalates demand for portable imaging options suitable for frequent routine assessments in elderly patients.
Recent Developments & News
In October 2024, Serac Imaging Systems announced the University of Malaya Medical Centre's presentation of findings on the clinical feasibility of Seracam®, a portable gamma-optical camera for breast cancer sentinel lymph node imaging, highlighting its advantages over standard probes.
In August 2024, Royal Shrewsbury Hospital launched a new gamma camera after a EUR 3.6 Million investment by Shrewsbury and Telford NHS Trust aimed at enhancing cancer and acute condition diagnostics.
In February 2024, M3D, Inc. received investment from Michigan Rise Pre-Seed Fund III to develop two gamma radiation detection cameras targeting safety, compliance, and intraoperative surgical use, with commercial release expected mid-2024.
Key Players
CMR Naviscan Corporation
Crystal Photonics GmbH
Mediso Ltd.
MiE GmbH
NUVIATech Instruments
Oncovision
Southern Scientific Ltd.
Spectrum Dynamics Medical
TTG Imaging Solutions
Get Custom Market Research Report for Your Business:
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302
Comments